List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 56 studies with search of: "Aprepitant"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study of Aprepitant (MK0869) and Fosaprepitant (MK0517) in Pediatric Patients Receiving Chemotherapy
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: aprepitant;   Drug: Comparator: fosaprepitant + aprepitant (Part I);   Drug: Comparator: ondansetron;   Drug: Comparator: aprepitant (Part IV);   Drug: Comparator: aprepitant + fosaprepitant (Part V)
2 Not yet recruiting Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
3 Recruiting A Randomized, Double-Blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Emend (Aprepitant) + Placebo;   Drug: Scopolamine + Emend (Aprepitant)
4 Recruiting Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Aprepitant;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Rituximab
5 Recruiting Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant;   Drug: Aprepitant
6 Recruiting Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Aprepitant, Dexamethasone, Ondansetron;   Drug: Aprepitant, Dexamethasone, Placebo
7 Completed Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: aprepitant;   Drug: Comparator: ondansetron;   Drug: Comparator: dexamethasone;   Drug: Comparator: fosaprepitant dimeglumine;   Drug: Comparator; Placebo (unspecified);   Drug: Comparator; Placebo (unspecified)
8 Recruiting Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Scopolamine
9 Terminated Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: aprepitant 40 mg;   Drug: ondansetron 4 mg
10 Completed Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
Condition: Cancer
Interventions: Drug: Aprepitant vs. Gabapentin;   Drug: Aprepitant vs. Gabapentin
11 Enrolling by invitation Emend for Multiple-Day Emetogenic Chemotherapy
Conditions: Chemotherapy Induced Nausea;   Vomiting
Intervention: Drug: aprepitant
12 Recruiting A Study of Aprepitant (MK0869) in Pediatric Patients Undergoing Surgery
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: aprepitant;   Drug: Comparator: Ondansetron
13 Recruiting Effectiveness of Aprepitant in the Treatment of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Outpatient Plastic Surgery
Condition: Postoperative Nausea and Vomiting (PONV)
Interventions: Drug: Aprepitant plus Ondansetron;   Drug: Ondansetron plus placebo
14 Not yet recruiting Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
Condition: Emesis
Interventions: Drug: Aprepitant;   Drug: dexamethasone
15 Not yet recruiting Aprepitant in the Prevention of Cisplatin-Induced Delayed Emesis
Condition: Emesis
Interventions: Drug: aprepitant + dexamethasone;   Drug: metoclopramide + dexamethasone
16 Recruiting Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Aprepitant + Dexamethasone;   Drug: Ondansetron + Dexamethasone
17 Recruiting Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Aprepitant;   Drug: Placebo
18 Recruiting Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Condition: Tumor
Interventions: Drug: aprepitant;   Drug: Dexamethasone and Ondansetron during CE-treatment
19 Recruiting Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
Condition: Germ Cell Tumors
Interventions: Drug: Aprepitant;   Drug: Placebo
20 Completed Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: MK0869, aprepitant / Duration of Treatment: 3 days;   Drug: Comparator: ondansetron / Duration of Treatment: 4 days

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services